GSK-3beta inhibitor 7 is a GSK-3beta inhibitor with an IC50 value of 5.25 µM. GSK-3beta inhibitor 7 is inserted into the ATP-binding binding pocket of GSK-3beta and forms hydrogen-bond. GSK-3beta inhibitor 7 shows high hepatocyte glucose uptake (83.5%), and can be used in the research of numerous diseases like diabetes, inflammation, cancer, Alzheimers disease, and bipolar disorder[1].
Molecular Weight:
547.47
Formula:
C27H23BrN4O2S
Target:
GSK-3
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
